{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:34:36Z","timestamp":1782779676715,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.esmoop.2024.103658","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T16:43:49Z","timestamp":1722617029000},"page":"103658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study"],"prefix":"10.1016","volume":"9","author":[{"given":"D.","family":"Trapani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pellizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carnevale Schianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Katrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Valenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2024.103658_bib1","series-title":"Multislice CT","first-page":"261","article-title":"Interstitial lung diseases","author":"Mueller-Mang","year":"2017"},{"issue":"3","key":"10.1016\/j.esmoop.2024.103658_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.1446","article-title":"Pathogenetic mechanisms in usual interstitial pneumonia\/idiopathic pulmonary fibrosis","volume":"201","author":"White","year":"2003","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.esmoop.2024.103658_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-13-39","article-title":"Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches","volume":"13","author":"Matsuno","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.esmoop.2024.103658_bib4","series-title":"Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table","year":"2021"},{"issue":"4","key":"10.1016\/j.esmoop.2024.103658_bib5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1164\/ajrccm.150.4.7921471","article-title":"The epidemiology of interstitial lung diseases","volume":"150","author":"Coultas","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.esmoop.2024.103658_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103658_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jsps.2018.04.010","article-title":"A\u00a0comprehensive review on Brigatinib - a wonder drug for targeted cancer therapy in non-small cell lung cancer","volume":"26","author":"Bedi","year":"2018","journal-title":"Saudi Pharm J"},{"issue":"2","key":"10.1016\/j.esmoop.2024.103658_bib8","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.cllc.2017.10.008","article-title":"Lung toxicity in non-small-cell lung cancer patients exposed to ALK inhibitors: report of a peculiar case and systematic review of the literature","volume":"19","author":"Pellegrino","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2024.103658_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.esmoop.2024.103658_bib10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10147-014-0764-5","article-title":"Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma","volume":"20","author":"Nozawa","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2024.103658_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.2004.08.185","article-title":"Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma","volume":"22","author":"Atkins","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103658_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1634\/theoncologist.2017-0343","article-title":"Emerging perspectives on mTOR inhibitor-associated pneumonitis in breast cancer","volume":"23","author":"Alvarez","year":"2018","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103658_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1165\/rcmb.2018-0044OC","article-title":"Alveolar micromechanics in bleomycin-induced lung injury","volume":"59","author":"Knudsen","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.esmoop.2024.103658_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00007890-200109150-00008","article-title":"Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients","volume":"72","author":"Morelon","year":"2001","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.esmoop.2024.103658_bib15","first-page":"356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.esmoop.2024.103658_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jclinepi.2003.12.008","article-title":"Time-dependent bias was common in survival analyses published in leading clinical journals","volume":"57","author":"van Walraven","year":"2004","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.esmoop.2024.103658_bib17","first-page":"356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.esmoop.2024.103658_bib18","first-page":"00630","article-title":"The prevalence and burden of interstitial lung diseases in the USA","volume":"8","author":"Jeganathan","year":"2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.esmoop.2024.103658_bib19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","article-title":"A\u00a0primer on interstitial lung disease and thoracic radiation","volume":"15","author":"Goodman","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"137","key":"10.1016\/j.esmoop.2024.103658_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/16000617.0050-2015","article-title":"Smoking and interstitial lung diseases","volume":"24","author":"Margaritopoulos","year":"2015","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.esmoop.2024.103658_bib21","doi-asserted-by":"crossref","first-page":"100554","DOI":"10.1016\/j.esmoop.2022.100554","article-title":"Pooled analysis of drug-related interstitial lung disease and\/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies","volume":"7","author":"Powell","year":"2022","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.esmoop.2024.103658_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab deruxtecan in previously treated HER2-positive breast cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.esmoop.2024.103658_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.esmoop.2024.103658_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","article-title":"Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials","volume":"152","author":"Khunger","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.esmoop.2024.103658_bib25","first-page":"1750050","article-title":"Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients","volume":"50","author":"Delaunay","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.esmoop.2024.103658_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0036-1582013","article-title":"Many faces of bronchiolitis and organizing pneumonia","volume":"37","author":"Cordier","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.esmoop.2024.103658_bib27","doi-asserted-by":"crossref","first-page":"101332","DOI":"10.1016\/j.xcrm.2023.101332","article-title":"Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers","volume":"4","author":"Nardo","year":"2023","journal-title":"Cell Rep Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702924014273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702924014273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:07:09Z","timestamp":1737331629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702924014273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2059702924014273"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2024.103658","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2024.103658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"103658"}}